Arkuda Therapeutics takes in $64m Series B

Arkuda Therapeutics, a biotechnology company, has raised $64 million in Series B financing.

Arkuda Therapeutics, a biotechnology company, has raised $64 million in Series B financing. Cormorant Asset Management and Pivotal bioVenture Partners led the round.

Source: Press Release